Abstract 3466: ALT-positive pediatric high grade glioma cells display chemosensitivity to ATR pathway inhibition
Jacqueline A. Brosnan‐Cashman(Johns Hopkins University), Alan K. Meeker(Johns Hopkins University), Christine Davis(Johns Hopkins University), Charles G. Eberhart(The University of Texas MD Anderson Cancer Center), Dinesh Rakheja(Southwestern Medical Center), Kaylar M. Myers(Johns Hopkins University), Eric H. Raabe(Johns Hopkins University), Christopher M. Heaphy(Boston University), Anthony Rizzo(Johns Hopkins University), Reza Zarinshenas(Johns Hopkins University), Ming Yuan(Johns Hopkins University), Ezgi Göger(Johns Hopkins University)
Cited by 0
Related Papers
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711